People living with schizophrenia will have access to a whole new class of medicine following the US Food and Drug Administration (FDA) approval of the drug ‘Cobenfy’. World first: Australian ...
Internationally acclaimed cardiac pharmacologist, Professor Rebecca Ritchie, has been named as a 2024 Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) ...